Rupert Capiña

552 total citations
16 papers, 322 citations indexed

About

Rupert Capiña is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Rupert Capiña has authored 16 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 9 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Rupert Capiña's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Rupert Capiña is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Rupert Capiña collaborates with scholars based in Canada, Kenya and United States. Rupert Capiña's co-authors include Steve Whyard, Aditi Singh, Nigel W. Beebe, Cassidy N. G. Erdelyan, Hezhao Ji, Francis A. Plummer, Joshua Kimani, Ma Luo, Gary Van Domselaar and Paul Sandstrom and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Rupert Capiña

16 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rupert Capiña Canada	9	161	139	125	86	55	16	322
Marina E. Biedma France	9	210 1.3×	97 0.7×	80 0.6×	34 0.4×	177 3.2×	13	351
Federico A. De Maio Argentina	7	84 0.5×	108 0.8×	196 1.6×	47 0.5×	67 1.2×	12	404
Victoria E. Walker-Sperling United States	9	168 1.0×	58 0.4×	80 0.6×	118 1.4×	134 2.4×	14	356
Benjamin Götte Sweden	8	48 0.3×	142 1.0×	171 1.4×	26 0.3×	80 1.5×	10	366
Ant Crook United Kingdom	6	54 0.3×	102 0.7×	81 0.6×	14 0.2×	28 0.5×	6	261
Xiaomi Xin Japan	8	225 1.4×	80 0.6×	113 0.9×	14 0.2×	143 2.6×	11	356
Laura A. Byk Argentina	6	49 0.3×	71 0.5×	165 1.3×	47 0.5×	30 0.5×	6	331
Lieke van der Aa United States	3	38 0.2×	130 0.9×	205 1.6×	81 0.9×	69 1.3×	3	413
Adam J. López‐Denman Australia	8	58 0.4×	63 0.5×	121 1.0×	36 0.4×	49 0.9×	14	275
Patrícia A. G. C. Silva Netherlands	6	31 0.2×	116 0.8×	134 1.1×	68 0.8×	100 1.8×	7	353

Countries citing papers authored by Rupert Capiña

Since Specialization

Citations

This map shows the geographic impact of Rupert Capiña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Capiña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Capiña more than expected).

Fields of papers citing papers by Rupert Capiña

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupert Capiña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Capiña. The network helps show where Rupert Capiña may publish in the future.

Co-authorship network of co-authors of Rupert Capiña

This figure shows the co-authorship network connecting the top 25 collaborators of Rupert Capiña. A scholar is included among the top collaborators of Rupert Capiña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupert Capiña. Rupert Capiña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Capiña, Rupert, et al.. (2024). A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens. Journal of Virological Methods. 327. 114939–114939. 1 indexed citations

Cholette, François, Paul Sandstrom, Helgar Musyoki, et al.. (2023). HIV acquisition prior to entry into formal sex work: inference from next-generation viral sequencing. AIDS. 37(6). 987–992. 5 indexed citations

Capiña, Rupert, et al.. (2022). Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials. Pathogens. 11(7). 724–724. 10 indexed citations

Cholette, François, Jeffrey B. Joy, Yann Pelcat, et al.. (2020). HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. PLoS ONE. 15(8). e0237560–e0237560. 7 indexed citations

Jennings, Cheryl, Neil Parkin, Daniel J. Zaccaro, et al.. (2020). Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses. 12(12). 1456–1456. 4 indexed citations

Capiña, Rupert, et al.. (2020). Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework. Viruses. 12(6). 645–645. 7 indexed citations

Enns, Eric, Binhua Liang, Rupert Capiña, et al.. (2019). A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance. Scientific Reports. 9(1). 8970–8970. 33 indexed citations

Ji, Hezhao, Eric Enns, Chanson J. Brumme, et al.. (2018). Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus. Journal of the International AIDS Society. 21(10). e25193–e25193. 29 indexed citations

Whyard, Steve, et al.. (2015). Silencing the buzz: a new approach to population suppression of mosquitoes by feeding larvae double-stranded RNAs. Parasites & Vectors. 8(1). 96–96. 109 indexed citations

10.

Luo, Ma, Rupert Capiña, Charles Wachihi, et al.. (2013). Immunogenicity of sequences around HIV-1 protease cleavage sites: Potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites. Vaccine. 31(29). 3000–3008. 14 indexed citations

11.

McKinnon, Lyle R., Nico Nagelkerke, Rupert Kaul, et al.. (2012). HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort. PLoS ONE. 7(11). e49797–e49797. 7 indexed citations

12.

Liang, Binhua, Ma Luo, Christina A. D. Semeniuk, et al.. (2011). A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1. PLoS ONE. 6(10). e26745–e26745. 33 indexed citations

13.

Luo, Ma, Tamsir O. Diallo, Rupert Capiña, et al.. (2011). For Protection from HIV-1 Infection, More Might Not Be Better: a Systematic Analysis of HIV Gag Epitopes of Two Alleles Associated with Different Outcomes of HIV-1 Infection. Journal of Virology. 86(2). 1166–1180. 19 indexed citations

14.

Semeniuk, Christina A. D., Rupert Capiña, Joshua Kimani, et al.. (2009). Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approach. Journal of Immunological Methods. 352(1-2). 118–125. 7 indexed citations

15.

McKinnon, Lyle R., Rupert Capiña, Joshua Kimani, et al.. (2009). Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1 p24. Journal of Virology. 83(23). 12636–12642. 12 indexed citations

16.

Capiña, Rupert, Ma Luo, Michael J. Gubbins, et al.. (2007). An Integrative Bioinformatic Approach for Studying Escape Mutations in Human Immunodeficiency Virus Type 1gagin the Pumwani Sex Worker Cohort. Journal of Virology. 82(4). 1980–1992. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact